Doxofylline 400 mg SR (Sustained Release) and Montelukast 10 mg Tablets are a combination medication designed for the management of asthma and chronic obstructive pulmonary disease (COPD). This innovative formula combines the bronchodilator properties of Doxofylline with the leukotriene receptor antagonist benefits of Montelukast, providing effective relief from breathing difficulties, wheezing, and shortness of breath associated with respiratory conditions.
This medication is primarily used in the treatment of:
It helps in controlling symptoms such as wheezing, shortness of breath, and chest tightness.
While most individuals do not experience significant side effects, some may notice:
Consult your healthcare provider if you experience persistent or severe side effects.
Take this medication exactly as prescribed by your healthcare provider. It is usually taken once daily, with or without food. Do not crush, chew, or break the tablet; swallow it whole to ensure the sustained release of medication.
Doxofylline acts as a bronchodilator, relaxing the muscles in the airways and making breathing easier. Montelukast works by blocking the action of leukotrienes, substances in the body that cause asthma and allergy symptoms. Together, they provide synergistic effects to improve respiratory function.
Store at room temperature, away from light and moisture. Keep out of reach of children and pets.
Doxofylline 400 mg SR and Montelukast 10 mg Tablets by JoinHub Pharma, exemplifies pharmaceutical excellence, meticulously crafted to exceed industry standards. Renowned for our unwavering commitment to quality, as WHO-GMP and EU-GMP Manufacturers, suppliers, and exporters, we assure unparalleled efficacy and reliability.
For further information on Doxofylline 400 mg SR and Montelukast 10 mg Tablets, please contact us via email at [email protected] or call us at +91-9724725604.